Scholars Central

CommentaryPublished 1 Sep 2022

Helicobacter pylori Eradication and the Role of Probiotics.

Authors: Nikos Viazis

Journal of Basic and Clinical Pharmacy

Volume 13 · Issue 8 · Pages 143

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Helicobacter pylori (H. pylori) infection is the leading cause for the development of chronic active gastritis, gastroduodenal ulcers, gastric mucosa-associated lymphoid tissue lymphoma and gastric cancer. As a result, several eradication regimens for H. pylori infection have been recommended by national and international guidelines. These regimens have been repeatedly modified over the years to overcome the evolving resistance of H. pylori strains to antibiotics. Recently, the Hellenic Society of Gastroenterology convened a consensus meeting and recommended that a concomitant non-bismuth quadruple regimen of a Proton Pump Inhibitor (PPI), amoxicillin, clarithromycin, and metronidazole for at least 10 days be the preferred first-line therapy in Greece, because it is associated with higher H. pylori eradication rates. Non-bismuth triple regimens have showed superior effectiveness in several trials and are now a feasible alternative, particularly in countries where bismuth is unavailable, such as Greece.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Basic and Clinical Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Nikos Viazis”